Job cuts at Roche Holding AG — which owns Genentech, based in South San Francisco and San Mateo County, Calif. — are scheduled to take place across the company in 2011 and 2012.
(Ryan Anson/ Bloomberg News/ File 2008)
Genentech example raises flags for Genzyme
One year after being bought, firm could see jobs trimmed
Job cuts at Roche Holding AG — which owns Genentech, based in South San Francisco and San Mateo County, Calif. — are scheduled to take place across the company in 2011 and 2012.
(Ryan Anson/ Bloomberg News/ File 2008)
A cost-cutting push unveiled Friday by the Swiss drug maker Roche Holding AG, which last year paid $46.8 billion for the US biotechnology giant Genentech Inc., has raised fresh questions about the fate of Genzyme Corp. , a Cambridge biotech. (Full article: 741 words)
This article is available in our archives:
Globe Subscribers
FREE for subscribers
Subscribers to the Boston Globe get unlimited access to our archives.
Not a subscriber?
Non-Subscribers
Purchase an electronic copy of the full article. Learn More
- $4.95 1 article
- $9.95 4 articles
- $25.95 Monthly
